SirYus technology easily adapts to blood screening tests and enables automated and low-cost multiplex tests for major pathologies: AIDS, hepatitis C (HVC) and hepatitis B (HVB), Syphilis (Treponema pallidum), HTLV I/II, Cytomegalovirus (CMV)…

SirYus technology combines two major advances that can disrupt the blood screening industry and standards:

  • The multiplex capabilities of SirYus enables simultaneous tests of numerous diseases from a single sample
  • High sensitivity and accuracy data
  • Small sample volume needed
  • Automatable process
  • Standard equipment and consumables, driving high potential economies of scale